belactosin-a and Neoplasms

Belactosin A is a potent proteasome inhibitor isolated from Streptomyces metabolites. Here we show that a hydrophobic belactosin A derivative, dansyl-KF33955, can covalently, and specifically, affinity label the catalytic subunits of the 26S proteasome, which consists of the 20S protein degrading core particle and the 19S regulatory particles. The labeling of catalytic subunits proceeds faster in intact proteasomes in vivo than in isolated 20S core particles. These data suggest that the 19S regulatory particle may facilitate entry of the inhibitor into the 20S core particle. This cell-permeable chemical probe is an excellent tool with which to study the interactions of this proteasome inhibitor with proteasomes in intact cells.

Topics: Antineoplastic Agents; Catalytic Domain; Dipeptides; Drug Design; Erythrocytes; HeLa Cells; Humans; Inhibitory Concentration 50; Intercellular Signaling Peptides and Proteins; Lactones; Models, Chemical; Neoplasms; Peptides; Proteasome Endopeptidase Complex; Tandem Mass Spectrometry